1Nishifuji K,Sugai M,Amagai M. Staphylococcal exfoliative toxins:"meleeular scissors" of bacteria that attack the cutaneous defense barrier in mammals[J].Journal of Dermatological Science,2008,(01):21-31.
2Anzai H,Stanley JR,Amagai M. Production of low titers of antidesmoglein 1 IsG autoantibedies in aome patients with staphylococcal scalded skin syndrome[J].Journal of Investigative Dermatology,2006,(09):2139-2141.
5Hanakawa Y, Schechter NM, Lin C, et al. Molecular mechanisms of blister formation in bulllous impetigo and staphylococcal scalded skin syndrome[J]. J Clin Invest, 2002, 110(1) :53-60.
6Anzai H, Stanley JR, Amagai M. Production of low titers of anti-desmoglein 1 IgG autoantibodies in some patients with staphylococcal scalded skin syndrome [ J ]. J Invest dermatol, 2006, 126 (9):2139- 2141.
7Rago JV, Vath GM, Bohach GA, et al. Mutational analysis of the super-antigen staphylococcal exfoliative toxin A (ETA) [ J ] . J Immunol, 2000, 164(4) :2207-2213.
8Ladhani S. Recent developments in staphylococcal scalded skin syndrome[J]. Clin Microbial Infect, 2001, 7(6):301-307.
9Noguchi N, Nakaminami H, Nisbijima S, et al. Antimicrobial agent of susceptibilities and antiseptic resistance gene distribution among methi-cillin-resistant Staphylococcus aureus isolates from patients with impetigo and staphylococcal scalded skin syndrome[J]. J Clin Microbiol, 2006, 44(6) :2119-2125.
10Erduran E, Gedik Y, Sen Y. Successful treatment of reactive hemophagocytic syndrome with cyclosporine A and intravenous immunoglobulin[J] .Turk J Pediatr, 2000, d-2(2) :168-170.
